During the past decade, Azienda Ospedaliera D. Cotugno conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera D. Cotugno" #1 sponsor was "National Cancer Institute, Naples" with 4 trials, followed by "Azienda Ospedaliera Universitaria Integrata Verona" with 2 trials sponsored, "Avexa" with 1 trials sponsored, "Azienda Ospedaliero-Universitaria Careggi" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera D. Cotugno" #1 collaborator was "Agenzia Italiana del Farmaco" with 2 trials as a collaborator, "Azienda Sanitaria-Universitaria Integrata di Udine" with 2 trials as a collaborator and "University of Modena and Reggio Emilia" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera D. Cotugno" are "Ovarian Cancer" (3 trials), "COVID-19" (2 trials), "HIV Infections" (2 trials), "Chronic Heart Failure" (1 trials) and "Chronic Hypoxemia" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera D. Cotugno" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera D. Cotugno" are "Drug" (7 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sotrovimab" (2 trials), "carboplatin" (2 trials), "paclitaxel" (2 trials), "Bamlanivimab Etesevimab" (1 trials) and "Casirivimab-Imdevimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera D. Cotugno" are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera D. Cotugno". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Azienda Ospedaliera D. Cotugno, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera D. Cotugno, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".